☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC September Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Arirpiprazole (Abilify®) has been rejected for the treatment of moderate to severe manic episodes in bipolar 1 disorder and for the prevention of a new manic episode because the economic analysis was not sufficiently robust to gain acceptance.

Ropinirole prolonged release (Requip XL®) has been accepted for the treatment of idiopathic Parkinson’s disease in patients already taking ropinirole immediate release tablets and have attained adequate symptomatic control.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC September Update' by emailShare 'SMC September Update' on FacebookShare 'SMC September Update' on TwitterShare 'SMC September Update' on LinkedInShare 'SMC September Update' on reddit

atomic-wealth

No Comments to “SMC September Update”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.

governor
governor
governor
governor